Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases

Alessia Vignoli; Panteleimon Takis; Paolo Montuschi

doi:10.3389/fmolb.2023.1268001

Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases

Front Mol Biosci. 2023 Aug 30:10:1268001. doi: 10.3389/fmolb.2023.1268001. eCollection 2023.

Authors

Alessia Vignoli^{1

2

3}, Panteleimon Takis⁴, Paolo Montuschi^{5

6}

Affiliations

¹ Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy.
² Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy.
³ Consorzio Interuniversitario Risonanze Magnetiche MetalloProteine (CIRMMP), Sesto Fiorentino, Italy.
⁴ Department of Metabolism, Digestion and Reproduction, National Phenome Centre, Imperial College, London, United Kingdom.
⁵ Faculty of Medicine, Imperial College, National Heart and Lung Institute, London, United Kingdom.
⁶ Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Roma, Italy.

No abstract available

Keywords: biomarker discovery; metabolomics; molecular phenotyping; personalized medicine; pharmacometabolomics; respiratory diseases; targeted pharmacotherapies.

Publication types

Editorial